Sano Genetics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
60
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$11.4M
- Investors
-
23
Sano Genetics General Information
Description
Developer of a genetic research platform designed to facilitate a direct connection between users and researchers. The company's platform offers research into many common disorders, such as eczema, diabetes, and depression, as well as rare diseases like muscular dystrophy, enabling researchers to do research into personalized medicine and access dynamic health and genetic data sets, which could lead to new treatments and cures for diseases.
Contact Information
Website
www.sanogenetics.comCorporate Office
- 3rd Floor, 86-90 Paul Street
- London EC2A 4NE
- England, United Kingdom
Corporate Office
- 3rd Floor, 86-90 Paul Street
- London EC2A 4NE
- England, United Kingdom
Sano Genetics Timeline
Sano Genetics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC | 22-Jan-2024 | $11.4M | Completed | Generating Revenue | ||
| 11. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 9. Grant | 01-Jul-2022 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series A) | 10-Feb-2022 | Completed | Generating Revenue | |||
| 7. Seed Round | 25-Jan-2021 | Completed | Generating Revenue | |||
| 6. Grant | 01-Jan-2021 | Completed | Generating Revenue | |||
| 5. Grant | 01-Nov-2020 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jun-2020 | $61K | $664K | Completed | Generating Revenue | |
| 3. Grant | 01-Oct-2019 | $295K | $664K | Completed | Generating Revenue |
Sano Genetics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| B-1 Ordinary | ||||||||
| B Ordianry | ||||||||
| A Ordinary | ||||||||
| Seed | 468,612 | $0.000127 | $6.63 | $6.63 | 1x | $6.63 | 15.4% | |
| A Ordinary | 72,069 | $0.000127 | $1.76 | $1.76 | 1x | $1.76 | 2.37% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Sano Genetics Comparisons
Industry
Financing
Details
Sano Genetics Competitors (2)
One of Sano Genetics’s 2 competitors is Phase Genomics, a Venture Capital-Backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Phase Genomics | Venture Capital-Backed | Seattle, WA | ||||
| Arima Genomics | Venture Capital-Backed | San Diego, CA |
Sano Genetics Signals
Sano Genetics Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cambridge Angels | Angel Group | Minority | ||
| Mainspring Fund Services | PE-Backed Company | Minority | ||
| Plural (England) | Venture Capital | Minority | ||
| PharmStars | Accelerator/Incubator | |||
| Angel (individual) | Minority |
Sano Genetics FAQs
-
When was Sano Genetics founded?
Sano Genetics was founded in 2016.
-
Where is Sano Genetics headquartered?
Sano Genetics is headquartered in London, United Kingdom.
-
What is the size of Sano Genetics?
Sano Genetics has 60 total employees.
-
What industry is Sano Genetics in?
Sano Genetics’s primary industry is Biotechnology.
-
Is Sano Genetics a private or public company?
Sano Genetics is a Private company.
-
What is the current valuation of Sano Genetics?
The current valuation of Sano Genetics is .
-
What is Sano Genetics’s current revenue?
The current revenue for Sano Genetics is .
-
How much funding has Sano Genetics raised over time?
Sano Genetics has raised $26.6M.
-
Who are Sano Genetics’s investors?
Cambridge Angels, Mainspring Fund Services, Plural (England), PharmStars, and are 5 of 23 investors who have invested in Sano Genetics.
-
Who are Sano Genetics’s competitors?
Phase Genomics and Arima Genomics are competitors of Sano Genetics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process